4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-17-006853
CIK 0001373707operating
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:16 PM ET
Size
8.1 KB
Accession
0001209191-17-006853
Insider Transaction Report
Form 4
Watt Christopher
VP, Finance
Transactions
- Award
Restricted Stock Unit
2017-01-31+15,000→ 15,000 total→ Common Stock (15,000 underlying) - Award
Employee Stock Option (Right to Buy)
2017-01-30+60,000→ 60,000 totalExercise: $3.69Exp: 2027-01-29→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on January 31, 2020.
- [F3]Vests as to 6.25% of the shares on 4/30/2017 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/30/2021.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:16 PM ET
- Size
- 8.1 KB